SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
May 10, 2004
------------
Date of Report
(Date of Earliest Event Reported)
LipidViro Tech, Inc.
--------------------
(Exact Name of Registrant as Specified in its Charter)
Nevada 0-49655 87-0678927
------ ------- ----------
(State or other (Commission File No.) (IRS Employer I.D. No.)
Jurisdiction)
2120 South 700 East, #H183
Salt Lake City, Utah 84106
--------------------------
(Address of Principal Executive Offices)
(801) 583-9900
--------------
Registrant's Telephone Number
Anticline Uranium, Inc.
-----------------------
Former Name
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
Exhibit No. Exhibit Description
----------- -------------------
99 Press Release
* Summaries of any exhibit are modified in their entirety by this
reference to each exhibit.
Item 9. Regulation FD Disclosure
See Exhibit 99, Press Release dated May 10, 2004, a copy of which is
attached hereto and incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the Registrant has duly caused this Current Report to be signed on its
behalf by the undersigned hereunto duly authorized.
LIPIDVIRO TECH,INC.
DATED: 05/10/04 /s/ Kenneth P. Hamik
-------- ----------------------
Kenneth P. Hamik
President and Director